Partnership Expansion Capitalize on the existing Versiti collaboration to approach additional diagnostic networks and cancer centers for relapse leukemia and lymphoma testing, offering co-marketing, referral arrangements, and white-label flow cytometry services.

Niche Diagnostics Hematologics specializes in ∆N flow cytometry and cell sorting to identify abnormal relapse cells, a high value proposition for hospitals, cancer centers, and reference labs seeking specialized diagnostics.

Network Collaboration With a mid-sized footprint and growth potential, pursue partnerships with large reference labs and CROs to scale testing capacity, expand geographic reach, and accelerate adoption in West Coast and nationwide markets.

Data and Automation Leverage their digital footprint and lab workflows by offering LIMS integration, automated sample tracking, secure result delivery, and analytics to streamline reporting for clinicians.

Growth Readiness As a small to mid-size lab, Hematologics can benefit from scalable outsourcing, vendor onboarding, and targeted marketing to accelerate client acquisition and expand test menus.